Corbus Pharmaceuticals (3371.F) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.97
-1.57
-1.17
-0.77

Details

Expected EPS
-0.8813127939700001
Actual EPS
-1.0646814999999998
Surprise EPS
-0.18
Surprise Percent
-20.81%

Description

⁨Corbus Pharmaceuticals⁩ (⁦3371.F⁩) has reported earnings of ⁦-1.0646814999999998⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts